Products

   LEVETRACARE 500 (Levetiracetam 500 mg) is a next-generation antiepileptic medication known for its precise mechanism of action in modulating synaptic neurotransmitter release, thereby stabilizing electrical activity in the brain. It is highly effective as both monotherapy and adjunct therapy for various seizure types, offering flexibility in treatment planning. LEVETRACARE is particularly valued for its minimal drug interactions, making it suitable for patients on multiple medications. Its consistent bioavailability and predictable response help reduce seizure frequency, improve neurological stability, and enhance overall quality of life. Widely trusted by neurologists across India, including Kerala, LEVETRACARE 500 ensures reliable, long-term seizure control when used under proper medical supervision.